These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 19608565

  • 1. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Humaidan P, Papanikolaou EG, Tarlatzis BC.
    Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
    [Abstract] [Full Text] [Related]

  • 2. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC, Engin Ustun Y.
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [Abstract] [Full Text] [Related]

  • 3. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [Abstract] [Full Text] [Related]

  • 4. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY.
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [Abstract] [Full Text] [Related]

  • 5. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C.
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [Abstract] [Full Text] [Related]

  • 6. HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.
    Haas J, Kedem A, Machtinger R, Dar S, Hourvitz A, Yerushalmi G, Orvieto R.
    J Ovarian Res; 2014 Apr 03; 7():35. PubMed ID: 24694069
    [Abstract] [Full Text] [Related]

  • 7. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY, Elbaek HO, Alsbjerg B, Laursen RJ, Povlsen BB, Thomsen L, Humaidan P.
    Hum Reprod; 2015 Oct 03; 30(10):2387-95. PubMed ID: 26209535
    [Abstract] [Full Text] [Related]

  • 8. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep 03; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 9. GnRH agonist triggering: recent developments.
    Kol S, Humaidan P.
    Reprod Biomed Online; 2013 Mar 03; 26(3):226-30. PubMed ID: 23337420
    [Abstract] [Full Text] [Related]

  • 10. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
    Engmann L, Benadiva C.
    Semin Reprod Med; 2010 Nov 03; 28(6):506-12. PubMed ID: 21082510
    [Abstract] [Full Text] [Related]

  • 11. Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates.
    Radesic B, Tremellen K.
    Hum Reprod; 2011 Dec 03; 26(12):3437-42. PubMed ID: 21997895
    [Abstract] [Full Text] [Related]

  • 12. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
    Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM.
    Reprod Biomed Online; 2012 Feb 03; 24(2):134-41. PubMed ID: 22197130
    [Abstract] [Full Text] [Related]

  • 13. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb 03; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 14. GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
    Humaidan P, Kol S, Papanikolaou EG, Copenhagen GnRH Agonist Triggering Workshop Group.
    Hum Reprod Update; 2011 Feb 03; 17(4):510-24. PubMed ID: 21450755
    [Abstract] [Full Text] [Related]

  • 15. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L.
    Fertil Steril; 2012 Jun 03; 97(6):1316-20. PubMed ID: 22480822
    [Abstract] [Full Text] [Related]

  • 16. Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial.
    Elgindy EA, Sibai H, Mostafa MI, Gibreel A, Darwish E, Maghraby H.
    Hum Reprod; 2018 Jun 01; 33(6):1079-1086. PubMed ID: 29562260
    [Abstract] [Full Text] [Related]

  • 17. Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.
    Abdulkhalikova D, Bokal EV, Stimpfel M, Ciglar P, Korosec S.
    Front Endocrinol (Lausanne); 2022 Jun 01; 13():826411. PubMed ID: 35464066
    [Abstract] [Full Text] [Related]

  • 18. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
    Griesinger G, Diedrich K, Devroey P, Kolibianakis EM.
    Hum Reprod Update; 2006 Jun 01; 12(2):159-68. PubMed ID: 16254001
    [Abstract] [Full Text] [Related]

  • 19. Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?
    Orvieto R.
    J Ovarian Res; 2015 Aug 21; 8():60. PubMed ID: 26293447
    [Abstract] [Full Text] [Related]

  • 20. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
    Casper RF.
    Fertil Steril; 2015 Apr 21; 103(4):867-9. PubMed ID: 25712575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.